ASN
PTCT icon

Advisory Services Network’s PTC Therapeutics PTCT Stock Holding History

Advisory Services Network’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-169
Closed -$11.5K – 4023
2026
Q1 		$11.5K Buy
+169
New +$12K ﹤0.01% 3484
2025
Q4 		– Sell
-50
Closed -$3.07K – 3655
2025
Q3 		$3.07K Buy
+50
New +$2.6K ﹤0.01% 3681
2025
Q2 		– Sell
-5,721
Closed -$292K – 1834
2025
Q1 		$292K Buy
+5,721
New +$285K 0.01% 1318
2020
Q4 		– Sell
-69
Closed -$4.07K – 3618
2020
Q3 		$3K Buy
+69
New +$3.4K ﹤0.01% 2989

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Advisory Services Network's PTCT Position: Q2 2026 in Review

Advisory Services Network sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 169 shares — an estimated $11.5K sold.

Advisory Services Network first reported a position in PTCT in Q3 2020 and held it in 4 quarters. The position peaked at $292K in Q1 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Advisory Services Network reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Advisory Services Network sold 169 PTC Therapeutics shares in Q2 2026, an estimated $11.5K.
  • Advisory Services Network first reported a position in PTC Therapeutics in Q3 2020 and held it in 4 quarters.
  • Advisory Services Network's PTC Therapeutics position peaked at $292K in Q1 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.